Type 2 Diabetes

Latest News

Bariatric Surgery Associated With Decreased Mortality in Severely Obese Patients With Type 2 Diabetes

By

Jessica Nye, PhD

A retrospective, population-based matched cohort study was conducted to assess the impact of bariatric surgery on mortality among patients with type 2 diabetes and severe obesity.

Cytokeratin Linked to Cataract Progression in Patients With Type 2 Diabetes

By

Jodi McCaffrey, MA, FACHE

Researchers investigate cataract development by examining the anterior lens capsules of patients with and without diabetes.

Canagliflozin May Not Reduce Myocardial Infarction Risk in Patients With Type 2 Diabetes

By

Brandon May

Treatment with canagliflozin may not significantly lower risk for myocardial infarction among patients with type 2 diabetes and comorbid chronic kidney disease or among patients with diabetes who have a history of or have a high risk for CVD.

Short-Term Blood Pressure Variability in Type 2 Diabetes Unchanged by Dapagliflozin

By

Lauren Biscaldi

A team of researchers sought to assess the effects of dapagliflozin on short-term blood pressure variability indices through 24-hour ambulatory blood pressure monitoring in people with type 2 diabetes.

Hypertension, Albuminuria Common in Pediatric Type 2 Diabetes

By

Natasha Persaud

The prevalence of hypertension and albuminuria in pediatric patients with type 2 diabetes varies by race.

Study Finds Age at Diabetes Onset Significantly Associated With Incident Dementia

By

Lauren Biscaldi

Investigators sought to determine whether age at onset of diabetes is associated with incident dementia.

Preventive Aflibercept Injections May Stave Off Diabetic Eye Disease Progression

By

Lauren Biscaldi

A study shows periodic dosing can affect the development of proliferative diabetic retinopathy and diabetic macular edema.

Long-Term BP Variability Linked to Cardiovascular Mortality in T2D

By

Jessica Nye, PhD

The link between long-term blood pressure variability and cardiovascular outcomes were studied in individuals with type 2 diabetes.

Farxiga Approved for Patients With CKD at Risk of Progression

By

Diana Ernst, RPh

The approval was based on data from the DAPA-CKD trial, which compared dapagliflozin, an SGLT2 inhibitor, to placebo on renal outcomes and cardiovascular mortality in patients with CKD.

Short Sleep, not Insomnia Alone Associated With Increased Risk for Type 2 Diabetes

By

Jessica Nye, PhD

Researchers conducted a systematic review and meta-analysis about the association of insomnia disorder characterized by objective sleep duration with hypertension, diabetes, and body mass index.

Clinical Charts

Insulins

Insulin Pen Devices

Insulin Administration